Cargando…
Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline
Patients with a tumour-risk syndrome have a significantly increased risk of developing cancer during their lifetime. A positive family history of tumour disease or an unusually early age of onset may be indicative of a tumour risk syndrome. With the diagnosis of a tumour risk syndrome it is possible...
Autores principales: | Kratz, Christian Peter, Steinke-Lange, Verena, Spier, Isabel, Aretz, Stefan, Schröck, Evelin, Holinski-Feder, Elke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747895/ https://www.ncbi.nlm.nih.gov/pubmed/35027859 http://dx.doi.org/10.1055/a-1541-7912 |
Ejemplares similares
-
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1
por: Carton, Charlotte, et al.
Publicado: (2023) -
ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis
por: Evans, D. Gareth, et al.
Publicado: (2022) -
Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017) -
Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020) -
Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
por: Kumamoto, Tadashi, et al.
Publicado: (2021)